Synopsis Due to the COVID-19 pandemic, the global Monitoring Electrodes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully cons.....
SynopsisThe global Medical Imaging Stretcher Trolley market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical d.....
Synopsis Children have growing anatomy and the strength of the skeletal system is less. Therefore, medical conditions regarding orthopedics require special equipment to fix the deformation in bone, skeleton, and other dislocation. There is a wi.....
SynopsisAnti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) an.....
SynopsisThe global Cancer Stem Cells (CSCs) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Stem Cells (CSCs) in various end use industries. The expan.....
SynopsisThe global Autoimmune Diseases Treatment market size is expected to reach US$ 141030 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Autoimmune Diseases Treatment in various end use i.....
SynopsisThe global Ophthalmology Amniotic Membrane market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical dev.....
SynopsisWheeled Examination Lamp so constructed that an intense light is emitted through a slit; used for examination of the eye. The global Wheeled Examination Lamps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witne.....
SynopsisPegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in .....
SynopsisCRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older. Market Analysis and Insights: Global Crysvita Market The global Crysvita market was valued at US$ XX in 202.....
